INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST

Core Viewpoint - A class action lawsuit has been filed against Aquestive Therapeutics, Inc. by investors [1] Group 1 - The lawsuit is being handled by Pomerantz LLP, which is advising affected investors to contact them for further information [1] - The company is listed on NASDAQ under the ticker symbol AQST [1]